CCGA Workgroup: Difference between revisions
| [checked revision] | [checked revision] |
No edit summary |
No edit summary |
||
| Line 170: | Line 170: | ||
|Chu | |Chu | ||
|NeoGenomics Laboratories | |NeoGenomics Laboratories | ||
|- | |||
|Hannah | |||
|Wollenzien | |||
|Sanford Health | |||
|} | |} | ||